Risk Factors and the Impact of Multidrug-Resistant Bacteria on Community-Acquired Urinary Sepsis

Manuel Madrazo1, Ian López-Cruz1, Laura Piles1

  • 1Hospital Universitario Doctor Peset, 46017 Valencia, Spain.

Microorganisms
|June 15, 2023
PubMed

Insights

This study identified healthcare-associated urinary sepsis (US) as a key risk factor for multidrug-resistant bacteria (MDRB) in community-acquired US. While MDRB did not worsen hospital mortality, it showed a trend toward longer hospital stays.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Urology

Background:

  • Multidrug-resistant bacteria (MDRB) are a growing concern in healthcare settings.
  • Risk factors and outcomes for community-acquired urinary sepsis (US) due to MDRB remain understudied.
  • Understanding these factors is crucial for effective patient management and infection control.

Purpose of the Study:

  • To identify independent risk factors for MDRB in community-acquired US.
  • To evaluate the influence of MDRB on patient outcomes, including mortality and length of hospital stay.
  • To compare clinical characteristics and outcomes between MDRB and non-MDRB US cases.

Main Methods:

  • Prospective observational study involving 193 patients with community-acquired US admitted to a university hospital.
  • Comparison of epidemiological and clinical variables and outcomes between patients with MDRB and non-MDRB US.
  • Logistic regression analysis to determine independent risk factors for MDRB.

Main Results:

  • 33.7% of patients had US caused by MDRB, with a median age of 82 years.
  • Hospital mortality was 17.6% and did not differ significantly between MDRB and non-MDRB groups.
  • Healthcare-associated US was identified as an independent risk factor for MDRB; a non-significant trend towards longer hospital stays was observed in the MDRB group.

Conclusions:

  • The impact of MDRB on outcomes in community-acquired urinary sepsis was found to be mild.
  • Healthcare-associated urinary sepsis is a significant independent risk factor for developing MDRB infections.
  • Further research may be needed to explore optimal management strategies for MDRB in this patient population.

Related Concept Videos

Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
20
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
61
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
26
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
16
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
48
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
19